Four years after Sanofi shelled out $125 million for global rights to Biond Biologic | The company is handing back the tumor ...

Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.

DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...

SOUTH SAN FRANCISCO, Calif., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) reported a ...

Polaryx Logo PARAMUS, NJ, UNITED STATES, February 26, 2025 /EINPresswire / -- Polaryx Therapeutics , a late-stage clinical biotech company dev ...

The expansion of the advanced therapy medicinal products market is primarily fueled by the increasing incidence of chronic diseases. The rising prevalence of genetic disorders and cancer, along ...

The growing global prevalence of influenza, mainly due to the transmission of the virus through droplets from coughing and sneezing, is the primary driver for the need for influenza vaccination.

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

The US Food and Drug Administration (FDA ... The FDA granted approval of Merilog to Sanofi-Aventis U.S. LLC. “The FDA has now approved three biosimilar insulin products to treat diabetes,” said Peter ...

CLIP 3679 TIME 14:16:59 "THE OFFERING THAT THEY HAD GIVEN US WAS 1.3% IN, IN TIMES OF RAPID INFLATION...IT'S NOT ENOUGH. WE'RE TAKING A PAY CUT ESSENTIALLY."> She says they would also like to see ...

More US companies are hiring workers based on skills rather than college degrees, helping expand opportunities for millions of job seekers. While this shift benefits both workers and businesses ...

In March 2023, Sanofi and Novo came under fire from Sen. Bernie Sanders (I-Vt), who asked the companies to follow in the footsteps of fellow diabetes leader Eli Lilly and lower the price of their ...